Form 4: Bio-Key International Director Acquires Shares as Compensation

Cameron E. Williams, a director at Bio-Key International, acquired 2,587 shares of common stock as compensation for board meeting attendance fees.

Summary

• On November 7, 2024, Cameron E. Williams, a director of Bio-Key International, acquired 2,587 shares of common stock.
• The shares were issued under the Issuer's 2023 Stock Incentive Plan.
• The acquisition was in payment of board meeting attendance fees.
• Following the transaction, Williams directly owns 8,816 shares of Bio-Key International.
• The transaction was reported on November 8, 2024.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a standard compensation practice. The director's acquisition of shares aligns interests with shareholders, but it's not a major event.

Positives

• The acquisition of shares by a director demonstrates alignment with shareholder interests.

Industry Context

Directors receiving stock as compensation is a common practice to align their interests with those of the shareholders.

Comparison to Industry Standards

• Stock compensation for board members is a common practice across various industries, including technology companies like Bio-Key International.
• Companies such as Okta and CrowdStrike also utilize stock-based compensation for their directors to incentivize performance and align interests with shareholders.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder confidence.

Key Dates

Keywords

Form 4, Beneficial Ownership, Director, Stock Incentive Plan, Bio-Key International, BKYI, Compensation, Shares